New POC System Based on Small Magnetic Microspheres and Offering Great Analytical Performance

MagIA diagnostics presents a new POC system based on Small Magnetic Microspheres, combined with micro-magnets and fluorescent detection. The assay exploits high local gradients generated by micro-magnets to capture and trap locally immune complexes bound to magnetic microspheres and fluorescent antibodies.  

The immunological reaction takes place in a cartridge where reagents are integrated. A dedicated analyzer performs a fluorescent measurement within fifteen minutes. MagIA diagnostics strives to combine high sensitivity immuno-detection with low production costs, promoting affordable and reliable diagnostics accessibility in all regions of the world.  

The growing challenges of pandemic risk management for infectious diseases drives the need for decentralized diagnostic solutions. Most available diagnostic solutions are focusing on detecting a single parameter. However, the Center for Disease Control and Prevention estimates that about 10% of people in the United States infected with HIV are co-infected with Hepatitis B. More than 120 million high-risk populations need to be screened on an infectious disease panel in western countries alone. That is why HAS and WHO are both looking for assays providing full serological status on the 3 mains sexually transmitted diseases HIV, HCV and HBV.
Using capillary blood, MagIA diagnostics infectious diseases panel will detect pathogens that most commonly present a co-infection:  HIV, HCV and HBV.

We develop 2 kits that can be used alone or in combination 
Hepatitis B rapid screening assay (HBs-Ag, anti-HBs, anti-HBc) for the whole serological status on Hepatitis B (treat or vaccine).

Hepatitis C and HIV rapid screening assay (anti-HCV, anti-HIV, p24) for Hepatitis C seropositivity and early detection of HIV infection.

The rapid and accurate knowledge of the presence or absence of the related pathogens will help make timely decisions about treatment, vaccination, infection control, and patient return to work and fam